文献速递前列腺癌前列腺增生与排尿功能障碍

美国根治性前列腺切除术后尿失禁手术治疗管理的当代趋势

Contemporary trends in the surgical management of urinary incontinence after radical prostatectomy in the United States.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-06-21

研究纳入2003至2017年确诊局限性前列腺癌并接受根治性前列腺切除术的21,589例男性,分析术后尿失禁手术的趋势、费用与预测因素。中位随访5年期间740例(3.43%)接受至少一次尿失禁手术,共844例次手术;男性吊带最常见(47.5%),人工尿道括约肌次之(35.3%)且费用最高。代谢综合征相关疾病、辅助或挽救性放疗及神经系统合并症病史与尿失禁手术可能性增加独立相关。

要点

  • 21,589例根治性前列腺切除术后男性中,740例(3.43%)在中位5年随访内接受尿失禁手术。
  • 男性吊带最常见(47.5%),为多数患者(50%)的首选;人工尿道括约肌次之(35.3%),费用最高。
  • 代谢综合征相关疾病、辅助或挽救性放疗及神经系统合并症病史与尿失禁手术可能性增加独立相关。

核心结论

  • 男性吊带的使用先增加后减少,人工尿道括约肌使用保持稳定,尿道填充剂使用不常见。
  • 从费用角度看,人工尿道括约肌是最昂贵的选择。
  • 患者合并症病史与根治性前列腺切除术相关因素影响原发性或后续尿失禁干预措施的选择。

研究设计与样本

  • 研究查询Optum去标识化Clinformatics® Data Mart数据库,纳入2003至2017年确诊局限性前列腺癌并接受根治性前列腺切除术的21,589例男性。
  • 主要结局为尿失禁手术的实施情况,并获取和比较不同尿失禁手术的平均费用。
  • 通过多变量回归分析评估尿失禁手术的人口学与临床预测因素。

主要发现

  • 21,589例接受根治性前列腺切除术的局限性前列腺癌男性中,740例(3.43%)在中位5年随访期间接受至少一次尿失禁手术。
  • 共实施844例次尿失禁手术;男性吊带最常见(47.5%),费用居中等,且为多数患者(50%)的首选治疗。
  • 人工尿道括约肌使用率第二(35.3%),为最昂贵的治疗,且为32.3%患者的首选治疗。
  • 多变量分析显示,代谢综合征相关疾病、辅助或挽救性放疗以及神经系统合并症病史与尿失禁手术可能性增加独立相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify trends, costs, and predictors in the use of different surgical procedures for post-radical prostatectomy incontinence (PPI). MATERIALS AND METHODS: We identified 21,589 men who were diagnosed with localized prostate cancer (PCa) and treated with radical prostatectomy (RP) from 2003 to 2017. The primary outcome was the incontinence procedure performances. Optum's de-identified Clinformatics® Data Mart Database was queried to define the cohort of interest. The average costs of the different incontinence procedures were obtained and compared. Also, demographic, and clinical predictors of incontinence surgery were evaluated by multivariable regression analysis. RESULTS: Of the 21,589 men with localized PCa treated with RP, 740 (3.43%) underwent at least one incontinence procedure during a median of 5 years of follow-up. In total, there were 844 unique incontinence procedures. Male slings were the most common procedure (47.5%), had an intermediate cost compared to the other treatment options, and was the first-choice treatment for the majority of patients (50%). The use of an artificial urinary sphincter (AUS) was the second most common (35.3%), but also was the most expensive treatment and was first-choice-treatment for 32.3% of patients. On multivariable analysis, metabolic syndrome related disorders, adjuvant/salvage radiation therapy as well as a history of neurological comorbidities were independently associated with an increased likelihood of incontinence surgery. CONCLUSIONS: The receipt of male slings increased and then subsequently decreased, while AUS utilization was stable, and the use of urethral bulking agents was uncommon. From a cost standpoint, AUS was the most expensive option. Finally, patient's comorbidity history and RP related factors were found to influence the choice for primary or subsequent PPI interventions.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Del Giudice F, Huang J, Li S, et al. Contemporary trends in the surgical management of urinary incontinence after radical prostatectomy in the United States. Prostate Cancer Prostatic Dis. 2022. PMID: 35729329. doi:10.1038/s41391-022-00558-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。